(Q36196484)

12 August 2017

1 reference

title

Novel agents in development for the treatment of melanoma (English)

1 reference

12 August 2017

Ahmad A Tarhini

1

1 reference

PubMed ID

16022577

12 August 2017

Sanjiv S Agarwala

series ordinal

2

1 reference

PubMed ID

16022577

12 August 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

Expert Opinion on Investigational Drugs

12 August 2017

1 reference

12 August 2017

14

1 reference

12 August 2017

7

1 reference

12 August 2017

885-892

1 reference

Chemosensitisation of malignant melanoma by BCL2 antisense therapy

12 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.7.885

Understanding Ras: 'it ain't over 'til it's over'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.7.885

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.7.885

Incidence of BRAF oncogene mutation and clinical relevance for primary cutaneous melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.7.885

High frequency of BRAF mutations in nevi

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.7.885

BRAF mutation: a frequent event in benign, atypical, and malignant melanocytic lesions of the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.7.885

BRAF mutations are common somatic events in melanocytic nevi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.7.885

V599EB-RAF is an oncogene in melanocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.7.885

Heat shock protein-peptide complexes in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.7.885

The hsp110 and Grp1 70 stress proteins: newly recognized relatives of the Hsp70s

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.7.885

Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.7.885

The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.7.885

Integrin mediated signal transduction in oncogenesis: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.7.885

Role of the alpha v beta 3 integrin in human melanoma cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.7.885

The role of the integrin vitronectin receptor, alpha v beta 3 in melanoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.7.885

Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.7.885

Thalidomide is an inhibitor of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.7.885

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.7.885

Inhibition of NF-kappa B activity by thalidomide through suppression of IkappaB kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.7.885

Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.7.885

A pilot study of thalidomide in patients with progressive metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.7.885

Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.7.885

Temozolomide plus thalidomide in patients with advanced melanoma: results of a dose-finding trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.7.885

Phase II study of temozolomide plus thalidomide for the treatment of metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.7.885

Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.7.885

Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accomp

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.7.885

Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: comparison of prophylaxis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.7.885

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.7.885

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.7.885

Vaccination of Metastatic Melanoma Patients With Autologous Tumor-Derived Heat Shock Protein gp96-Peptide Complexes: Clinical and Immunologic Findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.7.885

10.1517/13543784.14.7.885

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

16022577